Mr. Cox has served as a member of our Board of Directors since June 2019. Mr. Cox served as Chief Executive Officer of Foundation Medicine, Inc. from February 2017 through February 2019, as a member of Foundation Medicine’s board of directors from February 2017 until July 2018, and in the additional role of President of Foundation Medicine from February 2018 until July 2018. Prior to Foundation Medicine, Mr. Cox served as Senior Vice President, Sales & Marketing at Genentech, Inc. from February 2010 until February 2017. Before joining Genentech, Mr. Cox served as President of CNS operations at UCB S.A., with responsibility for developing and commercializing therapeutics for diseases primarily related to the central nervous system. Prior to UCB BioPharma, Mr. Cox held senior commercial leadership roles with Sanofi-Aventis and Schering-Plough. Mr. Cox has been on the board of directors at SOPHiA GENETICS SA since July 2019. He has also served on the board of directors of SomaLogic, Inc. from September 2021 until January 2024, and as the Executive Chair of the board from October 2022 to March 2023. Mr. Cox has served on the board of directors of Standard BioTools Inc. from January 2024 to present. Mr. Cox received a BBA in finance from the University of Kentucky and an MBA from the University of Missouri.